Welcome to Gary's Education Center!
September is Prostate Cancer Awareness Month. If you've been screened and found out you have an Elevated PSA, click the button below to find out if you're a candidate for the Prostate Health Index (phi), a new FDA approved test that can help differentiate prostate cancer from benign prostate conditions in men with elevated PSA (1-4).
Gary the Prostate
If you are physician, click the Order Test button below to begin offering this test to patients in your practice.
33. You can initiate an order through our physician network by clicking the order test button below or calling 855-420-7140
Or, download our Patient Physician Discussion Guide to take to your next appointment.
- Catalona WJ, Partin AW, Sanda MG, et al. A Multi-Center Study of [−2]Pro-Prostate-Specific Antigen (PSA) in Combination with PSA and Free PSA for Prostate Cancer Detection in the 2.0 to 10.0 ng/mL PSA Range. The Journal of Urology. 2011;185(5):1650-1655.
- Loeb S, Sanda MG, Broyles DL, et al. The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer. The Journal of Urology. 2015;193(4):1163-1169
- Huang YQ, Sun T, Zhong WD, et al. Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer. Am J Clin Exp Urol 2014;2(4):343-350
- Lepor A, Catalona WJ, Loeb S. The Prostate Health Index: Its Utility In Prostate Cancer Detection. The Urologic Clinics of North America. 2016;43(1):1-6.
- National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection. Version 2.2018 – April 5, 2018
- https://www.cancer.gov/types/prostate/psa-fact-sheet (Accessed 4.20.19)
- https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/signs-symptoms.html (Accessed 184.108.40.206)